260 related articles for article (PubMed ID: 17101779)
1. Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma.
Burgermeister E; Chuderland D; Hanoch T; Meyer M; Liscovitch M; Seger R
Mol Cell Biol; 2007 Feb; 27(3):803-17. PubMed ID: 17101779
[TBL] [Abstract][Full Text] [Related]
2. MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma.
Burgermeister E; Seger R
Cell Cycle; 2007 Jul; 6(13):1539-48. PubMed ID: 17611413
[TBL] [Abstract][Full Text] [Related]
3. Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1.
Yao Z; Flash I; Raviv Z; Yung Y; Asscher Y; Pleban S; Seger R
Oncogene; 2001 Nov; 20(52):7588-96. PubMed ID: 11753637
[TBL] [Abstract][Full Text] [Related]
4. Casein-kinase-II-dependent phosphorylation of PPARgamma provokes CRM1-mediated shuttling of PPARgamma from the nucleus to the cytosol.
von Knethen A; Tzieply N; Jennewein C; Brüne B
J Cell Sci; 2010 Jan; 123(Pt 2):192-201. PubMed ID: 20026644
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-γ nuclear export.
Khateeb J; Kiyan Y; Aviram M; Tkachuk S; Dumler I; Fuhrman B
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):449-58. PubMed ID: 22155455
[TBL] [Abstract][Full Text] [Related]
7. Skp2 regulates subcellular localization of PPARγ by MEK signaling pathways in human breast cancer.
Cheng H; Meng J; Wang G; Meng Y; Li Y; Wei D; Fu C; Deng K; Shen A; Wang H; Dai S
Int J Mol Sci; 2013 Aug; 14(8):16554-69. PubMed ID: 23939428
[TBL] [Abstract][Full Text] [Related]
8. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation.
Raviv Z; Kalie E; Seger R
J Cell Sci; 2004 Apr; 117(Pt 9):1773-84. PubMed ID: 15075238
[TBL] [Abstract][Full Text] [Related]
9. Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation.
Duhamel S; Hébert J; Gaboury L; Bouchard A; Simon R; Sauter G; Basik M; Meloche S
Cancer Res; 2012 Feb; 72(3):626-35. PubMed ID: 22298595
[TBL] [Abstract][Full Text] [Related]
10. Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1).
Dwivedi Y; Rizavi HS; Zhang H; Roberts RC; Conley RR; Pandey GN
Int J Neuropsychopharmacol; 2009 Nov; 12(10):1337-54. PubMed ID: 19835659
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of extracellular signal-regulated kinase (ERK)-1/2 Is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-γ during polymicrobial sepsis.
Kaplan JM; Hake PW; Denenberg A; Nowell M; Piraino G; Zingarelli B
Mol Med; 2010; 16(11-12):491-7. PubMed ID: 20809049
[TBL] [Abstract][Full Text] [Related]
12. Na+/K+/Cl- cotransporter activates MAP-kinase cascade downstream to protein kinase C, and upstream to MEK.
Panet R; Eliash M; Atlan H
J Cell Physiol; 2006 Mar; 206(3):578-85. PubMed ID: 16222701
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
14. An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ.
Banks AS; McAllister FE; Camporez JP; Zushin PJ; Jurczak MJ; Laznik-Bogoslavski D; Shulman GI; Gygi SP; Spiegelman BM
Nature; 2015 Jan; 517(7534):391-5. PubMed ID: 25409143
[TBL] [Abstract][Full Text] [Related]
15. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.
Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
Proc Natl Acad Sci U S A; 2008 May; 105(19):6870-5. PubMed ID: 18463290
[TBL] [Abstract][Full Text] [Related]
16. Ras/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI.
Wood P; Mulay V; Darabi M; Chan KC; Heeren J; Pol A; Lambert G; Rye KA; Enrich C; Grewal T
J Biol Chem; 2011 Jul; 286(26):23077-92. PubMed ID: 21525007
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells.
d'Abramo C; Ricciarelli R; Pronzato MA; Davies P
J Neurochem; 2006 Aug; 98(4):1068-77. PubMed ID: 16787414
[TBL] [Abstract][Full Text] [Related]
18. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling.
Roy M; Li Z; Sacks DB
Mol Cell Biol; 2005 Sep; 25(18):7940-52. PubMed ID: 16135787
[TBL] [Abstract][Full Text] [Related]
19. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
20. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
